Colon Cancer Studies

The Cancer Institute collaborates with Benaroya Research Institute and the Digestive Disease Institute to offer colon cancer studies.

• A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III
   
• A Double Blinded Randomized Three Armed Phase II Trial of PledOx™ in Two Different Doses in Combination with FOLFOX6 Compared to Placebo + FOLFOX6 in Patients with Advanced Metastatic Colorectal (Stage IV) Cancer
   
• A Randomized, Double-Blind, Placebo-Controlled Phase III Study of Adjuvant Regorafinib Versus Placebo for Patients with Stage IV Colorectal Cancer after Curative Treatment of Liver Metastases

If you would like to talk with a clinical research coordinator about clinical research trials related to pancreas cancer, call the Cancer Clinical Research Unit Research hotline at (206) 342-6954.